tiprankstipranks
Staar Surgical Company (STAA)
NASDAQ:STAA
Want to see STAA full AI Analyst Report?

Staar Surgical (STAA) Stock Statistics & Valuation Metrics

569 Followers

Total Valuation

Staar Surgical has a market cap or net worth of $1.42B. The enterprise value is $1.39B.
Market Cap$1.42B
Enterprise Value$1.39B

Share Statistics

Staar Surgical has 49,788,494 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding49,788,494
Owned by Insiders
Owned by Institutions

Financial Efficiency

Staar Surgical’s return on equity (ROE) is -0.23 and return on invested capital (ROIC) is -11.26%.
Return on Equity (ROE)-0.23
Return on Assets (ROA)-0.17
Return on Invested Capital (ROIC)-11.26%
Return on Capital Employed (ROCE)-0.12
Revenue Per Employee206.95K
Profits Per Employee-69.53K
Employee Count1,157
Asset Turnover0.52
Inventory Turnover1.03

Valuation Ratios

The current PE Ratio of Staar Surgical is ―. Staar Surgical’s PEG ratio is -0.05.
PE Ratio
PS Ratio4.89
PB Ratio3.40
Price to Fair Value3.40
Price to FCF-29.21
Price to Operating Cash Flow-28.33
PEG Ratio-0.05

Income Statement

In the last 12 months, Staar Surgical had revenue of 239.44M and earned -80.45M in profits. Earnings per share was -1.62.
Revenue239.44M
Gross Profit182.42M
Operating Income-45.95M
Pretax Income-82.26M
Net Income-80.45M
EBITDA-37.22M
Earnings Per Share (EPS)-1.62

Cash Flow

In the last 12 months, operating cash flow was -50.19M and capital expenditures -4.79M, giving a free cash flow of -54.99M billion.
Operating Cash Flow-50.19M
Free Cash Flow-54.99M
Free Cash Flow per Share-1.10

Dividends & Yields

Staar Surgical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.07
52-Week Price Change66.22%
50-Day Moving Average25.98
200-Day Moving Average24.31
Relative Strength Index (RSI)47.46
Average Volume (3m)987.73K

Important Dates

Staar Surgical upcoming earnings date is Aug 12, 2026, After Close (Confirmed).
Last Earnings DateMay 13, 2026
Next Earnings DateAug 12, 2026
Ex-Dividend Date

Financial Position

Staar Surgical as a current ratio of 4.55, with Debt / Equity ratio of 10.58%
Current Ratio4.55
Quick Ratio3.74
Debt to Market Cap0.00
Net Debt to EBITDA3.08
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Staar Surgical has paid -1.81M in taxes.
Income Tax-1.81M
Effective Tax Rate0.02

Enterprise Valuation

Staar Surgical EV to EBITDA ratio is -28.35, with an EV/FCF ratio of -26.34.
EV to Sales4.41
EV to EBITDA-28.35
EV to Free Cash Flow-26.34
EV to Operating Cash Flow-30.82

Balance Sheet

Staar Surgical has $163.89M in cash and marketable securities with $37.29M in debt, giving a net cash position of $126.60M billion.
Cash & Marketable Securities$163.89M
Total Debt$37.29M
Net Cash$126.60M
Net Cash Per Share$2.54
Tangible Book Value Per Share$6.29

Margins

Gross margin is 76.43%, with operating margin of -19.19%, and net profit margin of -33.60%.
Gross Margin76.43%
Operating Margin-19.19%
Pretax Margin-34.36%
Net Profit Margin-33.60%
EBITDA Margin-15.54%
EBIT Margin-19.19%

Analyst Forecast

The average price target for Staar Surgical is $29.14, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$29.14
Price Target Upside16.20% Upside
Analyst ConsensusHold
Analyst Count9
Revenue Growth Forecast4.03%
EPS Growth Forecast70.55%

Scores

Smart Score8
AI Score